227 related articles for article (PubMed ID: 12118853)
1. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
Nathan MJ; Yin D; Eichwald EJ; Bishop DK
Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
[TBL] [Abstract][Full Text] [Related]
2. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
4. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
5. Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells.
Nathan MJ; Mold JE; Wood SC; Csencsits K; Lu G; Eichwald EJ; Bishop DK
J Immunol; 2004 Jun; 172(11):6626-33. PubMed ID: 15153477
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
7. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
8. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
Burrell BE; Lu G; Li XC; Bishop DK
J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
[TBL] [Abstract][Full Text] [Related]
9. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
10. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade.
Krill KT; Csencsits-Smith K; Wood SC; Faust S; Lu G; Bishop DK
Clin Dev Immunol; 2013; 2013():986859. PubMed ID: 23690829
[TBL] [Abstract][Full Text] [Related]
12. Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells.
Wood SC; Lu G; Burrell BE; Bishop DK
Am J Transplant; 2008 Oct; 8(10):2037-48. PubMed ID: 18828767
[TBL] [Abstract][Full Text] [Related]
13. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.
Larsen CP; Alexander DZ; Hollenbaugh D; Elwood ET; Ritchie SC; Aruffo A; Hendrix R; Pearson TC
Transplantation; 1996 Jan; 61(1):4-9. PubMed ID: 8560571
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.
Mungara AK; Brown DL; Bishop DK; Wood SY; Cederna PS
J Reconstr Microsurg; 2008 Apr; 24(3):189-95. PubMed ID: 18459087
[TBL] [Abstract][Full Text] [Related]
15. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
Brown DL; Bishop DK; Wood SY; Cederna PS
Plast Reconstr Surg; 2006 Jun; 117(7):2250-8. PubMed ID: 16772925
[TBL] [Abstract][Full Text] [Related]
16. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.
Rolls HK; Kishimoto K; Dong VM; Illigens BM; Sho M; Sayegh MH; Benichou G; Fedoseyeva EV
Transplantation; 2002 Oct; 74(7):1053-7. PubMed ID: 12394855
[TBL] [Abstract][Full Text] [Related]
17. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
18. Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154).
Hackstein H; Wang Z; Morelli AE; Kaneko K; Takayama T; Colvin BL; Bein G; Thomson AW
Am J Transplant; 2002 Aug; 2(7):609-17. PubMed ID: 12201361
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.
Lal G; Nakayama Y; Sethi A; Singh AK; Burrell BE; Kulkarni N; Brinkman CC; Iwami D; Zhang T; Bromberg JS
Transplantation; 2015 Sep; 99(9):1817-28. PubMed ID: 25839706
[TBL] [Abstract][Full Text] [Related]
20. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy.
Yin D; Ma L; Zeng H; Shen J; Chong AS
Transplantation; 2002 Aug; 74(3):345-54. PubMed ID: 12177612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
